Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.

Several pieces of evidence suggest that small RNA degradation products together with tRNase ZL appear to form another layer of the whole gene regulatory network. The degraded RNA such as a 5'-half-tRNA and an rRNA fragment function as small guide RNA (sgRNA) to guide the enzyme to target RNA. W...

Full description

Bibliographic Details
Main Authors: Sho Ninomiya, Mitsuoki Kawano, Takashi Abe, Tatsuya Ishikawa, Masayuki Takahashi, Masato Tamura, Yoshiaki Takahashi, Masayuki Nashimoto
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4346264?pdf=render
_version_ 1817990231926767616
author Sho Ninomiya
Mitsuoki Kawano
Takashi Abe
Tatsuya Ishikawa
Masayuki Takahashi
Masato Tamura
Yoshiaki Takahashi
Masayuki Nashimoto
author_facet Sho Ninomiya
Mitsuoki Kawano
Takashi Abe
Tatsuya Ishikawa
Masayuki Takahashi
Masato Tamura
Yoshiaki Takahashi
Masayuki Nashimoto
author_sort Sho Ninomiya
collection DOAJ
description Several pieces of evidence suggest that small RNA degradation products together with tRNase ZL appear to form another layer of the whole gene regulatory network. The degraded RNA such as a 5'-half-tRNA and an rRNA fragment function as small guide RNA (sgRNA) to guide the enzyme to target RNA. We were curious whether there exist RNAs in plasma that can function as sgRNAs for tRNase ZL, whether these RNAs are working as signaling molecules between cells to fulfill physiological roles, and whether there are any differences in plasma sgRNA species and levels between normal and pathological conditions. Here, we analyzed small plasma RNAs from three healthy persons and three multiple myeloma patients for potential sgRNAs by deep sequencing. We also examined small RNAs from peripheral blood mononuclear cells (PBMC) of three healthy persons and three myeloma patients and from various cultured human cell lines for sgRNAs. We found that read-number distribution patterns of plasma and PBMC RNAs differ between persons in the range of 5-40 nt and that there are many RNA species that exist significantly more or less abundantly in the plasma or PBMC of the myeloma patients than those of the healthy persons. Furthermore, we found that there are many potential sgRNAs in the 5-40-nt RNAs and that, among them, a 31-nt RNA fragment derived from 94-nt Y4-RNA, which can function as a 5'-half-tRNA-type sgRNA, is overwhelmingly abundant in the plasma of 2/3 of the examinees. These observations suggest that the gene regulatory network via tRNase ZL and sgRNA may be extended intercellularly.
first_indexed 2024-04-14T00:56:46Z
format Article
id doaj.art-e7c71fe80c5144bb964bd4368b79c4f0
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T00:56:46Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e7c71fe80c5144bb964bd4368b79c4f02022-12-22T02:21:35ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011863110.1371/journal.pone.0118631Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.Sho NinomiyaMitsuoki KawanoTakashi AbeTatsuya IshikawaMasayuki TakahashiMasato TamuraYoshiaki TakahashiMasayuki NashimotoSeveral pieces of evidence suggest that small RNA degradation products together with tRNase ZL appear to form another layer of the whole gene regulatory network. The degraded RNA such as a 5'-half-tRNA and an rRNA fragment function as small guide RNA (sgRNA) to guide the enzyme to target RNA. We were curious whether there exist RNAs in plasma that can function as sgRNAs for tRNase ZL, whether these RNAs are working as signaling molecules between cells to fulfill physiological roles, and whether there are any differences in plasma sgRNA species and levels between normal and pathological conditions. Here, we analyzed small plasma RNAs from three healthy persons and three multiple myeloma patients for potential sgRNAs by deep sequencing. We also examined small RNAs from peripheral blood mononuclear cells (PBMC) of three healthy persons and three myeloma patients and from various cultured human cell lines for sgRNAs. We found that read-number distribution patterns of plasma and PBMC RNAs differ between persons in the range of 5-40 nt and that there are many RNA species that exist significantly more or less abundantly in the plasma or PBMC of the myeloma patients than those of the healthy persons. Furthermore, we found that there are many potential sgRNAs in the 5-40-nt RNAs and that, among them, a 31-nt RNA fragment derived from 94-nt Y4-RNA, which can function as a 5'-half-tRNA-type sgRNA, is overwhelmingly abundant in the plasma of 2/3 of the examinees. These observations suggest that the gene regulatory network via tRNase ZL and sgRNA may be extended intercellularly.http://europepmc.org/articles/PMC4346264?pdf=render
spellingShingle Sho Ninomiya
Mitsuoki Kawano
Takashi Abe
Tatsuya Ishikawa
Masayuki Takahashi
Masato Tamura
Yoshiaki Takahashi
Masayuki Nashimoto
Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.
PLoS ONE
title Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.
title_full Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.
title_fullStr Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.
title_full_unstemmed Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.
title_short Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.
title_sort potential small guide rnas for trnase zl from human plasma peripheral blood mononuclear cells and cultured cell lines
url http://europepmc.org/articles/PMC4346264?pdf=render
work_keys_str_mv AT shoninomiya potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines
AT mitsuokikawano potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines
AT takashiabe potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines
AT tatsuyaishikawa potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines
AT masayukitakahashi potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines
AT masatotamura potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines
AT yoshiakitakahashi potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines
AT masayukinashimoto potentialsmallguidernasfortrnasezlfromhumanplasmaperipheralbloodmononuclearcellsandculturedcelllines